S Weller - Concepedia

Author

S Weller

Also Known As

R Turco, S Radosevich, S WELLER, S Weller, S. Weller, SAMANTHA L WELLER, Sol W. Weller, Stephen A Weller, Stephen A. Weller, Stephen Weller

102

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)Stanford University University of Alabama at Birmingham Burroughs Wellcome Fund

About

S Weller is an author at Research Triangle Park Foundation specializing in medicine, pharmacokinetics, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	427
2	Nephrology	2	2	77
3	Medical Laboratory Science	1	1	16
4	Newborn Medicine	1	1	112
5	Obstetrics	1	1	83

S Weller

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Safety and Efficacy of High-Dose Intravenous Acyclovir in the Management of Neonatal Herpes Simplex Virus Infections David W. Kimberlin, Chin‐Yu Lin, Richard F. Jacobs, PEDIATRICS	2001	572
Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single-and multiple-dose administration to normal volunteers S Weller, Martin Blum, M Doucette, Clinical Pharmacology & Therapeutics	1993	394
The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group study (protocol 082) Mary J. O’Sullivan, Pamela Boyer, Gwendolyn B. Scott, American Journal of Obstetrics and Gynecology	1993	158
Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus François D. Boucher, John F. Modlin, S Weller, The Journal of Pediatrics Maternal ImmunizationPediatricsNewborn MedicineHivHuman Immunodeficiency Virus	1993	112
Initial relapses in previously treated Hodgkin's disease.I. Results of second treatment S Weller, Eli Glatstein, Henry S. Kaplan, Cancer Surgical OncologyDisease ProgressionImmunodeficienciesCancer ManagementPathology	1976	84
Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy Debora F. Kimberlin, S Weller, Richard J. Whitley, American Journal of Obstetrics and Gynecology Oral ContraceptiveMedicineGynecologyMaternal HealthPharmacotherapy	1998	83
Population Pharmacokinetics and Pharmacodynamic Modeling of Abacavir (1592U89) from a Dose-Ranging, Double-Blind, Randomized Monotherapy Trial with Human Immunodeficiency Virus-Infected Subjects S Weller, Kristine M. Radomski, Yu Lou, Antimicrobial Agents and Chemotherapy	2000	71
Pharmacokinetics of Acyclovir and Its Metabolites in Cerebrospinal Fluid and Systemic Circulation after Administration of High-Dose Valacyclovir in Subjects with Normal and Impaired Renal Function James P. Smith, S Weller, Benjamin Johnson, Antimicrobial Agents and Chemotherapy Therapeutic Drug MonitoringCerebrospinal FluidChronic Kidney DiseasePharmacologySerial Csf	2009	65
Pharmacokinetics and Safety of Extemporaneously Compounded Valacyclovir Oral Suspension in Pediatric Patients from 1 Month through 11 Years of Age David W. Kimberlin, Richard F. Jacobs, S Weller, Clinical Infectious Diseases	2009	60
Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment S Weller, Julie Borland, Shuguang Chen, European Journal of Clinical Pharmacology	2013	59

Page 1